Nalbuphine side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Nalbuphine. Common side effects include drug hypersensitivity among females, and drug hypersensitivity among males.
The phase IV clinical study is created by eHealthMe based on 1,044 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,044 people who take Nalbuphine and have side effects are studied.
What is Nalbuphine?
Nalbuphine has active ingredients of nalbuphine hydrochloride. Currently, eHealthMe is studying from 1,046 Nalbuphine users.
Number of Nalbuphine reports submitted per year:
Nalbuphine side effects by time on the drug *:
Nalbuphine side effects by gender *:
Nalbuphine side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Nalbuphine?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on nalbuphine hydrochloride (the active ingredients of Nalbuphine) and Nalbuphine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Nalbuphine:
- Nalbuphine (1,046 reports)
All Nalbuphine side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xiidra and Neuralgia - 37 seconds ago
- Lantus Solostar and Aromasin drug interaction - 52 seconds ago
- Drisdol and Xopenex Hfa drug interaction - 53 seconds ago
- Lovenox and Cerebral Ischaemia - a minute ago
- Diclofenac Sodium and Arava drug interaction - a minute ago
- Augmentin and Type I Hypersensitivity - a minute ago
- Avastin and Cholinergic Syndrome - 2 minutes ago
- Methadone Hydrochloride and Vomiting Aggravated - 2 minutes ago
- Methadone Hydrochloride and Weight Decreased - 2 minutes ago
- Heparin Lock Flush and Zetia drug interaction - 2 minutes ago